Rigel Dermatology赞助的临床试验
总计1015个结果
-
National Research Center for Hematology, Russia招聘中
-
Duke UniversityAmerican Society of Hematology招聘中
-
Institute of Hematology & Blood Diseases Hospital招聘中
-
Institute of Hematology & Blood Diseases Hospital招聘中
-
Institute of Hematology & Blood Diseases Hospital招聘中
-
Institute of Hematology & Blood Diseases Hospital招聘中
-
Institute of Hematology & Blood Diseases Hospital招聘中
-
Hematology department of the 920th hospital招聘中
-
Institute of Hematology & Blood Diseases Hospital尚未招聘
-
National Research Center for Hematology, Russia招聘中
-
National Research Center for Hematology, Russia招聘中
-
National Research Center for Hematology, Russia尚未招聘血液系统恶性肿瘤 | 移植物抗宿主病 | 环磷酰胺不良反应
-
Institute of Hematology & Blood Diseases Hospital招聘中
-
Institute of Hematology & Blood Diseases Hospital招聘中
-
Institute of Hematology & Blood Diseases Hospital招聘中
-
Hellenic Society of HematologyJanssen Pharmaceuticals完全的
-
National Research Center for Hematology, Russia主动,不招人
-
Institute of Hematology & Blood Diseases Hospital未知多发性骨髓瘤 | 浆细胞白血病 | 髓外浆细胞瘤 | 染色体 17p 丢失 | t(14;16) | t(4;14) | 复杂核型 | T(14;20) | 1Q21放大中国
-
Institute of Hematology & Blood Diseases Hospital未知
-
Hellenic Society of HematologyJanssen Pharmaceuticals未知
-
National Research Center for Hematology, Russia未知
-
Institute of Hematology & Blood Diseases Hospital未知
-
Institute of Hematology & Blood Diseases Hospital未知
-
National Research Center for Hematology, Russia未知
-
Institute of Hematology & Blood Diseases Hospital未知排尿障碍 | 血栓形成 | 蛋白尿 | 贫血、溶血 | 阵发性血红蛋白尿 | 血红蛋白尿 | 阵发性睡眠性血红蛋白尿 | 骨髓衰竭 | 再生障碍性贫血,中国
-
Cooperative Study Group A for Hematology未知
-
Cooperative Study Group A for Hematology完全的
-
Cooperative Study Group A for Hematology完全的
-
Cooperative Study Group A for Hematology未知
-
University of Michigan Rogel Cancer CenterTakeda撤销
-
University of Michigan Rogel Cancer CenterExelixis主动,不招人
-
University of Michigan Rogel Cancer CenterGlaxoSmithKline终止
-
University of Michigan Rogel Cancer CenterGlaxoSmithKline主动,不招人
-
University of Michigan Rogel Cancer CenterPfizer终止